Patients with diabetes mellitus who use GLP-1 RAs have an increased risk for acute and chronic pancreatitis, according to a study presented at DDW 2025.

Data-driven clustering reveals distinct obesity phenotypes with unique clinical, behavioral, microbiome features, and differential GLP-1 responses.

Brown, MD, and Victoria Francois, MPH, discuss strategies to address the gap in sleep inequalities affecting Black women.

Involvement of clinicians, including primary care physicians, endocrinologists, and rheumatologists, as appropriate, can ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic ...

Metformin and SGLT2 inhibitors are associated with similar rates of incident gout among patients with type 2 diabetes.

In a sudden about-face, HHS said it won't slash funding for the Women's Health Initiative, a major research project focused on preventing disease in older women.

US Health and Human Services Secretary Robert F Kennedy Jr is preparing to launch a multimillion-dollar public health campaign.

For patients with myocardial infarction (MI), early oral combination lipid-lowering therapy (LLT) is beneficial.

GLP-1RA use, but not SGLT2i or pioglitazone use, was associated with a statistically significant lower risk for dementia and cognitive impairment.

The link between asthma and type 2 diabetes is not only due to BMI; shared environmental and genetic risk factors may also play a role.